Search research articles
Contact Us
Filters
Showing results (41-50 of 53) with videos related to
Page
of 6
Sort By:
International Journal of Oncology
|
April 11, 2001
Potentiation of antitumor activity of irinotecan by chemically modified oligonucleotides
S Agrawal, E R Kandimalla, D Yu, et al.
British Journal of Cancer
|
May 5, 2011
Vatalanib for metastatic gastrointestinal stromal tumour (GIST) resistant to imatinib: final results of a phase II study
H Joensuu, F De Braud, G Grignagni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 13, 2009
Docetaxel versus docetaxel alternating with gemcitabine as treatments of advanced breast cancer: final analysis of a randomised trial
H Joensuu, L Sailas, T Alanko, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 3, 2011
Very high quantitative tumor HER2 content and outcome in early breast cancer
H Joensuu, J Sperinde, M Leinonen, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
|
December 28, 2002
Characterization of dendritic cells generated in vivo by an E. coli derived chimeric dual receptor agonist
Larry E Kahn, Parul D Doshi, Kelly L McGarity, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 11, 2014
Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial
S Loi, S Michiels, R Salgado, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 1, 1997
A peptidomimetic that specifically inhibits human leukocyte antigen DRB1*0401-restricted T cell proliferation
S L Woulfe, C P Bono, M L Zacheis, et al.
Journal of Medical Genetics
|
September 6, 2005
The MDM2 promoter polymorphism SNP309T-->G and the risk of uterine leiomyosarcoma, colorectal cancer, and squamous cell carcinoma of the head and neck
P Alhopuro, S K Ylisaukko-Oja, W J Koskinen, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 2, 2012
Investigation of the binding pocket of human hematopoietic prostaglandin (PG) D2 synthase (hH-PGDS): a tale of two waters
John I Trujillo, James R Kiefer, Wei Huang, et al.
The Journal of Toxicological Sciences
|
March 1, 2021
Microphysiological systems in early stage drug development: Perspectives on current applications and future impact
Anna K Kopec, Ryuji Yokokawa, Nasir Khan, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 53) with videos related to
Sort By:
Page
of 6
International Journal of Oncology
|
April 11, 2001
Potentiation of antitumor activity of irinotecan by chemically modified oligonucleotides
S Agrawal, E R Kandimalla, D Yu, et al.
British Journal of Cancer
|
May 5, 2011
Vatalanib for metastatic gastrointestinal stromal tumour (GIST) resistant to imatinib: final results of a phase II study
H Joensuu, F De Braud, G Grignagni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 13, 2009
Docetaxel versus docetaxel alternating with gemcitabine as treatments of advanced breast cancer: final analysis of a randomised trial
H Joensuu, L Sailas, T Alanko, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 3, 2011
Very high quantitative tumor HER2 content and outcome in early breast cancer
H Joensuu, J Sperinde, M Leinonen, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
|
December 28, 2002
Characterization of dendritic cells generated in vivo by an E. coli derived chimeric dual receptor agonist
Larry E Kahn, Parul D Doshi, Kelly L McGarity, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 11, 2014
Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial
S Loi, S Michiels, R Salgado, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 1, 1997
A peptidomimetic that specifically inhibits human leukocyte antigen DRB1*0401-restricted T cell proliferation
S L Woulfe, C P Bono, M L Zacheis, et al.
Journal of Medical Genetics
|
September 6, 2005
The MDM2 promoter polymorphism SNP309T-->G and the risk of uterine leiomyosarcoma, colorectal cancer, and squamous cell carcinoma of the head and neck
P Alhopuro, S K Ylisaukko-Oja, W J Koskinen, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 2, 2012
Investigation of the binding pocket of human hematopoietic prostaglandin (PG) D2 synthase (hH-PGDS): a tale of two waters
John I Trujillo, James R Kiefer, Wei Huang, et al.
The Journal of Toxicological Sciences
|
March 1, 2021
Microphysiological systems in early stage drug development: Perspectives on current applications and future impact
Anna K Kopec, Ryuji Yokokawa, Nasir Khan, et al.
Page
of 6